Qifeng Qiu

This inventor holds 1 USPTO granted patent. Top assignee: Axolabs Gmbh. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qifeng Qiu. Retrieved from https://idiyas.com/inventor/qifeng-qiu-iz97mghl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qifeng Qiu: Innovator in Muscle Targeting Complexes

Introduction

Qifeng Qiu is a notable inventor recognized for his contributions to the field of medical science. He has developed innovative solutions aimed at treating specific muscular disorders. His work is particularly focused on facioscapulohumeral muscular dystrophy, a condition that affects muscle strength and function.

Latest Patents

Qifeng Qiu holds a patent for "Muscle Targeting Complexes and Formulations for Treating Facioscapulohumeral Muscular Dystrophy." This patent represents a significant advancement in therapeutic approaches for this challenging condition. He has successfully secured 1 patent that showcases his commitment to improving patient outcomes.

Career Highlights

Qifeng Qiu is currently employed at Axolabs GmbH, where he continues to push the boundaries of innovation in medical treatments. His role at the company allows him to collaborate with other experts in the field, enhancing the development of effective therapies.

Collaborations

Throughout his career, Qifeng has worked alongside talented colleagues such as Timothy Weeden and Nelson Hsia. These collaborations have fostered a dynamic environment for research and development, leading to impactful advancements in their shared field.

Conclusion

Qifeng Qiu's work exemplifies the spirit of innovation in medical science. His dedication to developing targeted treatments for muscular dystrophy highlights the importance of research and collaboration in addressing complex health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…